25Jan
Financial Daily Dose 1.25.2021 | Top Story: Merck Abandons Covid Vaccine Effort Over Ineffective Results
U.S. drug giant Merck is shuttering its coronavirus vaccine development “after early trial data showed [its pair of vaccines] failed to generate immune responses comparable to natural infection or existing vaccines.”...
By:
Robins Kaplan LLP
Related
In a decision that extends the FTC's winning streak in the courts of appeals in healthcare provider ...
Read More >
Recently, the National Labor Relations Board (NLRB) issued another pro-employer decision, resolving ...
Read More >
Seyfarth Synopsis: Employers were handed a big win recently when the U.S. Court of Appeals for the ...
Read More >
On December 20, 2019, President Trump signed into law H.R. 1865, the Further Consolidated Appropriat...
Read More >
In re Appraisal of Panera Bread Co., C.A. No. 2017-0593-MTZ (Del. Ch. Jan. 31, 2020). JAB Holdings ...
Read More >
1. Cost is an overused consideration for picking plan providers, value and quality are underused. 2...
Read More >